Rainer Strohmenger

Rainer Strohmenger is the current managing partner at Wellington Partners, a position they have held since 2015. Prior to this, they were with eGenesis, Inc. as their Chief Executive Officer from 2014-2015. From 2012-2014 they served as the CEO of Adrenomed AG. From 2009-2012, they worked as the CEO of AMBOSS. Aignostics was their employer from 2007-2009 where they worked as their CEO. iOmx Therapeutics AG employed him from 2005-2007 as their CEO. 4SC AG was their employer from 2002-2005 where they worked in Business Development. Prior to 2002, they worked for Wellington Partners Life Sciences and Sphingotec GmbH in Business Development.

Rainer Strohmenger received their MSc/MBA in Economics from Ludwig-Maximilians-Universität München and their Ph.D./M.D. in Medicine from Ludwig-Maximilians-Universität München. Rainer also received their Abitur in 1.3 from Carl-von-Linde Gymnasium Kempten.

Erich Schlick - Venture Partner, Mel Spigelman - Venture Partner, and Stuart Essig - Venture Partner report to Rainer Strohmenger.